Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung CancerNobuyuki Takahashi, Anish Thomas, Jorge J. Nieva et al.|JAMA Oncology|2023Cited by 50
Abstract CT169: Poziotinib administered twice daily improves safety and tolerability in patients with EGFR or HER2 exon 20 mutant NSCLC(ZENITH20-5)Xiuning Le, Mark A. Socinski, Elaine Shum et al.|Cancer Research|2021Cited by 9
Innovative approaches for lung cancer screening and interceptionJianjun Zhang, Miriam Mérad, M S Park et al.|Nature Reviews Clinical Oncology|2026Cited by 3
Abstract LB_A10: Efficacy of ATR inhibitor berzosertib plus topotecan or topotecan alone in patients with relapsed small cell lung cancer: A randomized clinical trialNobuyuki Takahashi, Anish Thomas, Zhonglin Hao et al.|Molecular Cancer Therapeutics|2023Cited by 0